Viral safety of blood derivatives: an overview
Related Experiment Videos
1Institut Pasteur, Paris, France.
Clinical Therapeutics
|January 1, 1996
Abstract:
The causes of past accidental viral transmissions associated with blood derivatives are reviewed briefly, as are the safety procedures instituted in Europe on the basis of viral validation studies. A comprehensive five-class classification system for delineating viral risk according to source material and comparative viral safety is presented. Newly emerging viruses are briefly discussed in view of the viral safety of blood products.